CROI 2015: European PrEP Studies Find High and Equivalent HIV Protection
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 24 February 2015 00:00
- Written by HIVandHepatitis.com
The UK PROUD study of once-daily Truvada (tenofovir/emtricitabine) pre-exposure prophylaxis (PrEP), and the French Ipergay study of "on-demand" PrEP taken before and after sex, both saw an 86% reduction in new HIV infections, researchers reported at the at the 2015 Conference on Retroviruses and Opportunistic Infections(CROI) this week in Seattle.
PrEP Stops 86% of HIV Infections in PROUD Study
On-Demand PrEP Prevents 86% of HIV Infections in Ipergay
PrEP Provides 86% Protection in 2 Studies [VIDEO]